je.st
news
Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases
2014-01-13 12:01:01| Biotech - Topix.net
Genzyme, a Sanofi company , and Alnylam Pharmaceuticals, Inc. announced today that they have significantly expanded their strategic agreement to develop and commercialize treatments for rare genetic diseases.
Tags: expand
rare
collaboration
diseases
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||